Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES

Detalles Bibliográficos
Autores principales: Boland, Brigid S., Goodwin, Benjamin, Zhang, Zeli, bloom, Nathaniel, Neill, Jennifer, Le, Helen, Collins, Angelina, Dulai, Parambir, Singh, Siddharth, Nguyen, Nghia H., Grifoni, Alba, Weiskopf, Daniella, Chang, John T., Dan, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212360/
http://dx.doi.org/10.1016/S0016-5085(22)62390-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212360/
http://dx.doi.org/10.1016/S0016-5085(22)62390-4

Ejemplares similares